Background Bronchoscopy is an integral component of the practice of respiratory medicine. Multiple challenges to establishing and maintaining a service in low income countries (LIC) are recognized, with establishing and maintaining bronchoscopic competence being a key barrier to implementation. A critical gap in care at the leading hospital in Dili, Timor-Leste, was identified following multiple adverse outcomes due to lack of bronchoscopy for management of foreign body aspiration (FBA) in 2023, including two deaths.

Methods A healthcare needs assessment (HCNA) was completed to identify setting-specific requirements, and a novel training program designed to rapidly upskill local clinicians for performance of emergency FBA retrieval.

Results HCNA revealed heightened risks (no negative pressure ventilation, limited anaesthetic staff capacity) and reduced diagnostic utility (lower lung cancer rates, no treatment for advanced cancer or TB strictures), but noted significant infrastructure and workforce capacity for bronchoscopy due to the endoscopy training program established by the Australian and New Zealand Gastroenterology International Training Association (ANZGITA). A novel training program, comprising short intensive skills training and ongoing remote mentorship (including ‘just-in-time procedural support) was implemented to rapidly upskill local HNGV clinicians. In the sixteen months following bronchoscopic training, three paediatric patients successfully underwent bronchoscopic removal of FBA without complications.

Conclusion This model demonstrates the value of intensive training and remote support for successful establishment of bronchoscopy for targeted indications, and offers a potential framework for other LICs to establish essential emergency bronchoscopy services despite resource limitations and low procedural volumes

The authors have declared no competing interest.

DPS receives part-salary support from an NHMRC Investigator Grant (GNT2008317)

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics committee of Research Ethics & Technical Committee of the National Institute of Public Health, Timor-Leste gave ethical approval for this work, with a waiver of informed consent approved (986/INSP-TL/UEPD-AL/VI/2025)

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present work are contained in the manuscript